Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 5906-5912

  Boonnak, Kobporn ^a,e   Vogel, Leatrice ^a   Feldmann, Friederike ^b   Feldmann, Heinz ^c   Legge, Kevin L ^d   Subbarao, Kanta ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 12P40;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL TRACKING; CELL TRANSFER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A (H5N1); LYMPH NODE; LYMPHOCYTE; LYMPHOCYTOPENIA; MALE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; DENDRITIC CELLS; FAS LIGAND PROTEIN; INFLUENZA A VIRUS, H5N1 SUBTYPE; INTERLEUKIN-12; LUNG; LYMPHOPENIA; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PLASMA CELLS; T-LYMPHOCYTES;

EID: 84902179128     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302992     Document Type: Article

References (36)

1. De Jong, J. C., E. C. Claas, A. D. Osterhaus, R. G. Webster, and W. L. Lim. 1997. A pandemic warning? Nature 389:554.
2. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, et al. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396.
3. Chen, Y., W. Liang, S. Yang, N. Wu, H. Gao, J. Sheng, H. Yao, J. Wo, Q. Fang, D. Cui, et al. 2013. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381:1916-1925.
4. Dybing, J. K., S. Schultz-Cherry, D. E. Swayne, D. L. Suarez, and M. L. Perdue. 2000. Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J. Virol. 74:1443-1450.
5. Gao, P., S. Watanabe, T. Ito, H. Goto, K. Wells, M. McGregor, A. J. Cooley, and Y. Kawaoka. 1999. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J. Virol. 73:3184-3189.
6. Gubareva, L. V., J. A. McCullers, R. C. Bethell, and R. G. Webster. 1998. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. J. Infect. Dis. 178:1592-1596.
7. Katz, J. M., X. Lu, T. M. Tumpey, C. B. Smith, M. W. Shaw, and K. Subbarao. 2000. Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74:10807-10810.
8. Tumpey, T. M., X. Lu, T. Morken, S. R. Zaki, and J. M. Katz. 2000. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J. Virol. 74:6105-6116.
9. Maines, T. R., X. H. Lu, S. M. Erb, L. Edwards, J. Guarner, P. W. Greer, D. C. Nguyen, K. J. Szretter, L. M. Chen, P. Thawatsupha, et al. 2005. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79:11788-11800.
10. Claas, E. C., A. D. Osterhaus, R. Van Beek, J. C. De Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge, and R. G. Webster. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477.
11. Suarez, D. L., M. L. Perdue, N. Cox, T. Rowe, C. Bender, J. Huang, and D. E. Swayne. 1998. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J. Virol. 72:6678-6688.
12. Lu, X., T. M. Tumpey, T. Morken, S. R. Zaki, N. J. Cox, and J. M. Katz. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73:5903-5911.
13. Chen, H., R. A. Bright, K. Subbarao, C. Smith, N. J. Cox, J. M. Katz, and Y. Matsuoka. 2007. Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. Virus Res. 128:159-163.
14. Fornek, J. L., L. Gillim-Ross, C. Santos, V. Carter, J. M. Ward, L. I. Cheng, S. Proll, M. G. Katze, and K. Subbarao. 2009. A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice. J. Virol. 83:11102-11115.
15. Yuen, K. Y., P. K. Chan, M. Peiris, D. N. Tsang, T. L. Que, K. F. Shortridge, P. T. Cheung, W. K. To, E. T. Ho, R. Sung, and A. F. Cheng. 1998. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467-471.
16. Hinshaw, V. S., C. W. Olsen, N. Dybdahl-Sissoko, and D. Evans. 1994. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol. 68:3667-3673.
17. Takizawa, T., S. Matsukawa, Y. Higuchi, S. Nakamura, Y. Nakanishi, and R. Fukuda. 1993. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol. 74:2347-2355.
18. Fesq, H., M. Bacher, M. Nain, and D. Gemsa. 1994. Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology 190:175-182.
19. Hofmann, P., H. Sprenger, A. Kaufmann, A. Bender, C. Hasse, M. Nain, and D. Gemsa. 1997. Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J. Leukoc. Biol. 61:408-414.
20. Criswell, B. S., R. B. Couch, S. B. Greenberg, and S. L. Kimzey. 1979. The lymphocyte response to influenza in humans. Am. Rev. Respir. Dis. 120:700-704.
21. Dolin, R., D. D. Richman, B. R. Murphy, and A. S. Fauci. 1977. Cell-mediated immune responses in humans after induced infection with influenza A virus. J. Infect. Dis. 135:714-719.
22. Topham, D. J., R. A. Tripp, and P. C. Doherty. 1997. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159:5197-5200.
23. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652.
24. Brincks, E. L., A. Katewa, T. A. Kucaba, T. S. Griffith, and K. L. Legge. 2008. CD8 T cells utilize TRAIL to control influenza virus infection. J. Immunol. 181:4918-4925.
25. Wolfe, T., C. Asseman, A. Hughes, H. Matsue, A. Takashima, and M. G. Von Herrath. 2002. Reduction of antiviral CD8 lymphocytes in vivo with dendritic cells expressing Fas ligand-increased survival of viral (lymphocytic choriomeningitis virus) central nervous system infection. J. Immunol. 169:4867-4872.
26. Legge, K. L., and T. J. Braciale. 2005. Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity 23:649-659.
27. Langlois, R. A., and K. L. Legge. 2010. Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells. J. Immunol. 184:4440-4446.
28. Fujikura, D., S. Chiba, D. Muramatsu, M. Kazumata, Y. Nakayama, T. Kawai, S. Akira, H. Kida, and T. Miyazaki. 2013. Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza. PLoS ONE 8:e55321.
29. Vogel, A. B., E. Haasbach, S. J. Reiling, K. Droebner, K. Klingel, and O. Planz. 2010. Highly pathogenic influenza virus infection of the thymus interferes with T lymphocyte development. J. Immunol. 185:4824-4834.
30. Logan, A. C., K. P. Chow, A. George, P. D. Weinstein, and J. J. Cebra. 1991. Use of Peyer's patch and lymph node fragment cultures to compare local immune responses to Morganella morganii. Infect. Immun. 59:1024-1031.
31. Sun, J., R. Madan, C. L. Karp, and T. J. Braciale. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15:277-284.
32. Hahne, M., M. C. Peitsch, M. Irmler, M. Schröter, B. Lowin, M. Rousseau, C. Bron, T. Renno, L. French, and J. Tschopp. 1995. Characterization of the nonfunctional Fas ligand of gld mice. Int. Immunol. 7:1381-1386.
33. Liem, N. T., C. V. Tung, N. D. Hien, T. T. Hien, N. Q. Chau, H. T. Long, N. T. Hien, Q. Mai Le, W. R. Taylor, H. Wertheim, et al. 2009. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin. Infect. Dis. 48:1639-1646.
34. Gao, H. N., H. Z. Lu, B. Cao, B. Du, H. Shang, J. H. Gan, S. H. Lu, Y. D. Yang, Q. Fang, Y. Z. Shen, et al. 2013. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N. Engl. J. Med. 368:2277-2285.
35. De Jong, M. D., C. P. Simmons, T. T. Thanh, V. M. Hien, G. J. Smith, T. N. Chau, D. M. Hoang, N. V. Chau, T. H. Khanh, V. C. Dong, et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207.
36. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Théry, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621-667